ReviewJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019
Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.
Review in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 40 citations in OpenAlex.
- In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.Circulation · 2024Review
- Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.Diagnostics (Basel, Switzerland) · 2024Review
- The Role of Multimodality Imaging in Cardiomyopathy.Current cardiology reports · 2024Review
- Review
- Cardiac Involvement in Neurosarcoidosis: A Single-Center InvestigationNeurology(R) neuroimmunology & neuroinflammation · 2024Article
- Potential clinical utility ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Cardiac Sarcoidosis: A Unique Presentation.Cureus · 2022Article
- T2 mapping in myocardial disease: a comprehensive review.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022Review
- Recent advances in PET-MRI for cardiac sarcoidosis.Frontiers in nuclear medicine · 2022Review
- Cases from a busy nuclear cardiology laboratory.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- BMIPP SPECT in cardiac sarcoidosis: A marker of risk?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- Multi-modality imaging: Bird's eye view from the 2020 American Heart Association Scientific Sessions.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Review
- Can phase analysis of gated myocardial perfusion single-photon emission computed tomography predict adverse outcome in cardiac sarcoidosis?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- Sarcoid Heart Disease: an Update on Diagnosis and Management.Current cardiology reports · 2020Review
- Infliximab Treatment of Refractory Cardiac Sarcoidosis.JACC. Case reports · 2020Article
- The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020Review
- TNF-alpha inhibition for the treatment of cardiac sarcoidosis.Seminars in arthritis and rheumatism · 2020Article
- Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Positron emission tomography, computed tomography and magnetic resonance.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020Review
- Radionuclide Imaging for Cardiac Sarcoidosis: Much Potential Benefit, but Still Much to Do.Annals of nuclear cardiology · 2020Review
- A new era of imaging for diagnosis and management of cardiac sarcoidosis: Hybrid cardiac magnetic resonance imaging and positron emission tomography.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Cardiac sarcoidosis (CS) remains an intriguing infiltrating disorder and one of the most important forms of inflammatory cardiomyopathy. Identification of patients with CS is of extreme importance because they are at higher risk of sudden death, and heart-failure progression. And while it remains a diagnostic conundrum, a great amount of experience has been accumulated over the last decade with the advent of fluorine-18 fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance with late gadolinium enhancement imaging. They have both proven to be advanced imaging techniques that provide important, and often complementary, diagnostic and prognostic information for the management of CS. However, they have also shown to have limitations, and, thus, there is a continued need for developing more specific imaging probes for identifying cardiac inflammation. The aim of the present manuscript is to provide the reader with a better understanding of the histopathology of the disease, how this potentially relates to noninvasive imaging detection, and the best strategies available for the diagnosis and management of patients with CS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.